Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Alloy Therapeutics
About
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
- Waltham,Massachusetts,United States
- https://www.alloytx.com
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $75M
- Industries
- Biopharma,Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 3, 2022 | Series D | $42M | 5 |
8VC
Mubadala Capital Ventures
|
— | Detail |
| Apr 2, 2021 | Series C | $75M | 10 |
8VC
Peter Thiel
Presight Capital
|
— | Detail |
| Jun 5, 2020 | Series B | $11.25M | 2 |
8VC
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 2, 2022
Vernal Biosciences
|
Series Unknown | $21M | Biotechnology | — |
|
Apr 6, 2022
Tegmine Therapeutics
|
Corporate Round | — | Biotechnology | Yes |
|
Mar 8, 2022
Mytide Therapeutics
|
Series A | $7M | Biotechnology | Yes |
|
Jan 4, 2022
Wheeler Bio
|
Seed | $14M | Biotechnology | Yes |
|
Jul 21, 2021
Wheeler Bio
|
Funding Round | — | Biotechnology | Yes |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
8VC
|
Yes | Series D |
|
Mubadala Capital Ventures
|
Yes | Series D |
|
Peter Thiel
|
Yes | Series C |
Founders Fund
|
— | Series D |
|
Presight Capital
|
— | Series D |
Thiel Capital
|
— | Series D |
Gaingels
|
— | Series C |
Alexandria Venture Investments
|
— | Series C |
Bossanova Investimentos
|
— | Series C |
|
|
— | Series C |
Employee Profiles
Acquisition
Alloy Therapeutics has acquired 1 organizations. Their most recent acquisition was deepCDR Biologics on Dec 9, 2021. They acquired deepCDR Biologics for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Dec 9, 2021
|
Biotechnology | acquisition | — | Detail |
